Catalyst overview
Research summary
This catalyst tracks a Phase 2 data readout for IMVT-1402 in Sjögren’s Disease (SjD). The expected timing is based on the latest available company guidance and may change.
05/20/26:- Sjögren’s disease trial remains on track; topline data expected in 2027. 08/06/26:- SjD topline data now expected in 2028.
Verification
Confirm timing and program details against the company announcement or filing.